Xenoport

Xenoport

A biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$15.9m

Series A
N/A

$2.0m

Grant

$43.9m

Series B

$37.0m

Series C

$25.0m

Series D
N/A

N/A

IPO
N/A

$20.0m

Late VC
N/A

$467m

Valuation: $467m

Acquisition
Total Funding€131m

Recent News about Xenoport

Edit
More about Xenoportinfo icon
Edit

Arbor Pharmaceuticals, based in Atlanta, Georgia, is a specialty pharmaceutical company focused on marketing prescription products across various therapeutic areas including cardiovascular, hospital, neuroscience, and pediatric markets. The company is led by a team of experienced pharmaceutical veterans, many of whom have backgrounds as healthcare practitioners, providing them with a deep understanding of the pharmaceutical development process and the value their products bring to patients' lives. Arbor Pharmaceuticals operates in the highly regulated pharmaceutical market, serving healthcare providers and patients who require specialized prescription medications. The business model revolves around the development, marketing, and sale of branded prescription products, with several products currently in late-stage development. Revenue is generated through the sale of these prescription medications to hospitals, clinics, and pharmacies. Arbor Pharmaceuticals aims to improve lives by advancing medicine, leveraging their expertise to bring innovative treatments to market.

Keywords: specialty pharmaceuticals, cardiovascular, hospital, neuroscience, pediatric, prescription products, healthcare practitioners, pharmaceutical development, branded products, innovative treatments.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.